Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mira Pavlovic

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Frontiers in Medicine|November 30, 2016
Challenges for Relative Effectiveness Assessment and Early Access of Cancer Immunotherapies in EuropeMira Pavlovic
JAMA Dermatology|May 17, 2013
Tick removal with liquid nitrogenMira Pavlovic, Abdullah Alakeel, Camille Frances
Therapie|April 16, 2016
[Not Available]Mira Pavlovic, Jérôme Garnier, Isabelle Durand-Zaleski, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 14, 2025
There is no sufficient evidence to recommend isotretinoin in folliculitis decalvansBruno Matard, Philippe Assouly, Pascal Reygagne, et al.
AIDS (London, England)|July 20, 2002
Efficacy of imiquimod on external anogenital warts in HIV-infected patients previously treated by highly active antiretroviral therapyPhilippe Saiag, Isabelle Bourgault-Villada, Mira Pavlovic, et al.
Hormone Research|December 7, 2007
Similar biological medicinal products containing recombinant human growth hormone: European regulationMira Pavlovic, Elizabeth Girardin, Liliana Kapetanovic, et al.
International Journal of Technology Assessment in Health Care|March 10, 2015
Endpoints for relative effectiveness assessment (REA) of pharmaceuticalsMira Pavlovic, Conor Teljeur, Beate Wieseler, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2014
Improving the contribution of regulatory assessment reports to health technology assessments--a collaboration between the European Medicines Agency and the European network for Health Technology AssessmentMichael Berntgen, Anne Gourvil, Mira Pavlovic, et al.
Vaccine|August 18, 2021
Vaccine market access pathways in the EU27 and the United Kingdom - analysis and recommendations for improvementsValérie Laigle, Maarten J Postma, Mira Pavlovic, et al.
Dermatology and Therapy|September 12, 2021
Beyond-Mild Psoriasis: A Consensus Statement on Calcipotriol and Betamethasone Dipropionate Foam for the Topical Treatment of Adult PatientsRoland Aschoff, Anthony Bewley, Annunziata Dattola, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Frontiers in Medicine|November 30, 2016
Challenges for Relative Effectiveness Assessment and Early Access of Cancer Immunotherapies in EuropeMira Pavlovic
JAMA Dermatology|May 17, 2013
Tick removal with liquid nitrogenMira Pavlovic, Abdullah Alakeel, Camille Frances
Therapie|April 16, 2016
[Not Available]Mira Pavlovic, Jérôme Garnier, Isabelle Durand-Zaleski, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 14, 2025
There is no sufficient evidence to recommend isotretinoin in folliculitis decalvansBruno Matard, Philippe Assouly, Pascal Reygagne, et al.
AIDS (London, England)|July 20, 2002
Efficacy of imiquimod on external anogenital warts in HIV-infected patients previously treated by highly active antiretroviral therapyPhilippe Saiag, Isabelle Bourgault-Villada, Mira Pavlovic, et al.
Hormone Research|December 7, 2007
Similar biological medicinal products containing recombinant human growth hormone: European regulationMira Pavlovic, Elizabeth Girardin, Liliana Kapetanovic, et al.
International Journal of Technology Assessment in Health Care|March 10, 2015
Endpoints for relative effectiveness assessment (REA) of pharmaceuticalsMira Pavlovic, Conor Teljeur, Beate Wieseler, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2014
Improving the contribution of regulatory assessment reports to health technology assessments--a collaboration between the European Medicines Agency and the European network for Health Technology AssessmentMichael Berntgen, Anne Gourvil, Mira Pavlovic, et al.
Vaccine|August 18, 2021
Vaccine market access pathways in the EU27 and the United Kingdom - analysis and recommendations for improvementsValérie Laigle, Maarten J Postma, Mira Pavlovic, et al.
Dermatology and Therapy|September 12, 2021
Beyond-Mild Psoriasis: A Consensus Statement on Calcipotriol and Betamethasone Dipropionate Foam for the Topical Treatment of Adult PatientsRoland Aschoff, Anthony Bewley, Annunziata Dattola, et al.
Pageof 3